Survivin selective inhibitor YM155 induce apoptosis in SK-NEP-1 Wilms tumor cells

被引：0
|
作者：
Yan-Fang Tao
Jun Lu
Xiao-Juan Du
Li-Chao Sun
Xuan Zhao
Liang Peng
Lan Cao
Pei-Fang Xiao
Li Pang
Dong Wu
Na Wang
Xing Feng
Yan-Hong Li
Jian Ni
Jian Wang
Jian Pan
机构：
[1] Children's Hospital of Soochow University,Department of Hematology and Oncology
[2] the 5th Hospital of Chinese PLA,Department of Gastroenterology
[3] Cancer Institute (Hospital),Department of Cell and Molecular Biology
[4] Chinese Academy of Medical Sciences,Institute of Clinical Medical Science
[5] Peking Union Medical College,Translational Research Center, Second Hospital
[6] Beijing Insititute for Drug Control,undefined
[7] China-Japan Friendship Hospital,undefined
[8] The Second Clinical School,undefined
[9] Nanjing Medical University,undefined
来源：
BMC Cancer | / 12卷
关键词：
YM155; SK-NEP-1; Survivin; Apoptosis; Real-time PCR array;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [11] Ablation of Sp1 binding to survivin core promoter (-149 to-68) by the survivin expression inhibitor YM155 is potentially involved in YM155 inhibition of survivin gene transcription
    Cheng, Qiuying
    Ling, Xiang
    Wu, Jianguo
    Nakahara, Takahito
    Yamanaka, Kentaro
    Takeuchi, Masahiro
    Brattain, Michael
    Li, Fengzhi
    CANCER RESEARCH, 2009, 69
  • [12] WARNING: G-401 and SK-NEP-1 cell lines are not Wilms tumor cell lines
    Pritchard-Jones, Kathy
    Perotti, Daniela
    PEDIATRIC BLOOD & CANCER, 2019, 66 (07)
  • [13] Induction of autophagy-dependent apoptosis by the survivin suppressant YM155 in prostate cancer cells
    Wang, Qinwen
    Chen, Zhengtang
    Diao, Xinwei
    Huang, Shengbing
    CANCER LETTERS, 2011, 302 (01) : 29 - 36
  • [14] TAT-IL-24-KDEL-induced apoptosis is inhibited by survivin but restored by the small molecular survivin inhibitor, YM155, in cancer cells
    Zhang, Jian
    Xu, Rui
    Tao, Xinyi
    Dong, Yuguo
    Lv, Xinxin
    Sun, Aiyou
    Wei, Dongzhi
    ONCOTARGET, 2016, 7 (24) : 37030 - 37042
  • [15] YM155 sensitizes HeLa cells to TRAIL-mediated apoptosis via cFLIP and survivin downregulation
    Chandrasekaran, Arun Pandian
    Poondla, Naresh
    Ko, Na Re
    Oh, Seung Jun
    Ramakrishna, Suresh
    ONCOLOGY LETTERS, 2020, 20 (04)
  • [16] THE INHIBITOR OF SURVIVIN EXPRESSION, YM155, SHOWS SUBTYPE-SPECIFIC ACTIVITY IN MALIGNANT MESOTHELIOMA CELLS
    Schedlich, Lyn J.
    Gattani, Sumedha
    Van Zandwijk, Nico
    Reid, Glen
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S941 - S941
  • [17] Anti-GD2 Immunoliposomes for Targeted Delivery of the Survivin Inhibitor Sepantronium Bromide (YM155) to Neuroblastoma Tumor Cells
    Shima Gholizadeh
    Emmy M. Dolman
    Rebecca Wieriks
    Rolf W. Sparidans
    Wim E. Hennink
    Robbert J. Kok
    Pharmaceutical Research, 2018, 35
  • [18] Small Molecule Survivin Inhibitor YM155 Displays Potent Activity Against Human Osteosarcoma Cells
    Zhang, Shufeng
    Wang, Xiaohui
    Gu, Zhimin
    Wang, Li
    CANCER INVESTIGATION, 2016, 34 (08) : 401 - 407
  • [19] Anti-GD2 Immunoliposomes for Targeted Delivery of the Survivin Inhibitor Sepantronium Bromide (YM155) to Neuroblastoma Tumor Cells
    Gholizadeh, Shima
    Dolman, Emmy M.
    Wieriks, Rebecca
    Sparidans, Rolf W.
    Hennink, Wim E.
    Kok, Robbert J.
    PHARMACEUTICAL RESEARCH, 2018, 35 (04)
  • [20] YM155 sensitizes ovarian cancer cells to cisplatin inducing apoptosis and tumor regression
    Mir, Roser
    Stanzani, Elisabetta
    Martinez-Soler, Fina
    Villanueva, Alberto
    Vidal, August
    Condom, Enric
    Ponce, Jordi
    Gil, Joan
    Tortosa, Avelina
    Gimenez-Bonafe, Pepita
    GYNECOLOGIC ONCOLOGY, 2014, 132 (01) : 211 - 220
12345